Everest Medicines Limited (FRA:6HN)

Everest Medicines Revenue

Everest Medicines had revenue of 446.12M CNY in the half year ending June 30, 2025, with 4,915.44% growth. This brings the company's revenue in the last twelve months to 851.28M, up 103.39% year-over-year. In the year 2024, Everest Medicines had annual revenue of 706.68M with 461.16% growth.

• Revenue (ttm): 851.28M CNY
• Revenue Growth: +103.39%
• P/S Ratio: 18.02
• Revenue / Employee: 1.28M CNY
• Employees: 665
• Market Cap: 1.82B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	706.68M	580.75M	461.16%
Dec 31, 2023	125.93M	113.14M	884.46%
Dec 31, 2022	12.79M	12.74M	23,588.89%
Dec 31, 2021	54.00K	-	-
Dec 31, 2020	-	-	-